SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899923-24-000025
Filing Date
2024-05-07
Accepted
2024-05-07 16:05:25
Documents
15
Period of Report
2024-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20240507.htm   iXBRL 8-K 37174
2 EX-99.1 mygn-xq124earningsreleasex.htm EX-99.1 308138
  Complete submission text file 0000899923-24-000025.txt   524610

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20240507.xsd EX-101.SCH 2140
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20240507_def.xml EX-101.DEF 14426
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20240507_lab.xml EX-101.LAB 25279
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20240507_pre.xml EX-101.PRE 15012
18 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20240507_htm.xml XML 2804
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 24921744
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)